Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Investigation of Complement Activation and Cytokine Signatures in AQP4+ NMOSD, MOGAD, and MS.
Cost-effectiveness of cladribine tablets for the treatment of active relapsing-remitting multiple sclerosis in the United Kingdom.
Menopause and Neurology: Clinical Essentials.
DNA donation decisions, uncertainty, and perceived learning in a Serbian survey on multiple sclerosis genetics.
Treatment-associated factors potentially linked to relapse in pediatric MOG antibody-associated disease: An exploratory case series.
Exercise-induced pain modulation in multiple sclerosis: Why pain phenotype matters.
Examining the effectiveness of theory-based nursing interventions for patients with multiple sclerosis (MS): A systematic review of randomized controlled trials.
Anisotropy of dipolar order relaxation rate in phospholipid bilayers.
Rapid bolus versus 3-h continuous infusion of 3% hypertonic saline for acute symptomatic hyponatremia.
Metabolomic Profiles Associated With Disease Severity in Multiple Sclerosis.
Clear Positive MOG Antibodies in Adults With Multiple Sclerosis Features: Diagnostic Challenges.
MOG Antibody Status Is Associated With Distinct Clinical Profiles and Treatment Responses in Chronic Relapsing Inflammatory Optic Neuropathy.
Gray Matter Damage and Long-Term Disability, Cognitive Outcome, and Survival in Patients With Multiple Sclerosis.
Construct validity and intrasession intra-rater reliability of the stair and step tests in individuals with multiple sclerosis.
Myelin Sheath-Inspired Fluorocarbon Hydrophobic Bridges for Stable n-Type Organic Mixed Ionic-Electronic Conductors.
Tuberculosis-Associated Longitudinally Extensive Transverse Myelitis.
Design, reporting, and research focus of neurology and psychiatry drug trials (2020-2023): a registry-based meta-epidemiological study using ClinicalTrials.gov and NLP.
Cellular senescence in ageing and neurodegenerative disorders: Molecular mechanisms, biomarkers, and therapeutic strategies.
Pan-neurofascinopathies: a subgroup that mimic other neuroimmune-mediated diseases.
Physical and psychological burden in RRMS: depression and fatigue beyond disease duration.
A One-Pot Synthesis of N-α-Functionalized Amides via Oxidative Four-Component Reaction of Alcohols, Amines, Carboxylic Acids, and Nucleophiles.
Design, Synthesis, and Characterization of Novel Small Molecule Antagonists of the GPR17 Receptor.
Nanobodies Equipped with HaloTag Enable Scalable Fluorescence-Lifetime Multiplexing.
Di-2-ethylhexyl Phthalate Induces Neurotoxicity of Transforming Microglia into M1 Subtype through Targeting α-Syn Dimerization.
Remibrutinib versus teriflunomide in relapsing multiple sclerosis (REMODEL-1 and REMODEL-2): two randomised, phase 3 trials.
Pages
« first
‹ previous
…
1131
1132
1133
1134
1135
1136
1137
1138
1139
next ›
last »